Back to today’s briefing

Story perspectives

AI Pioneer David Fajgenbaum Transforms Drug Discovery for Rare Disease

7/16/2025

34 3

Summary

Story summary

David Fajgenbaum, a former medical student, fought valiantly against the rare Castleman disease. Through relentless research, he uncovered a connection between his symptoms and sirolimus, leading to his remarkable remission. Now, as co-founder of Every Cure, he harnesses AI to uncover new uses for existing drugs, offering hope and potentially saving countless lives.

1 of 1

Story summary

David Fajgenbaum, a former medical student, fought valiantly against the rare Castleman disease. Through relentless research, he uncovered a connection between his symptoms and sirolimus, leading to his remarkable remission. Now, as co-founder of Every Cure, he harnesses AI to uncover new uses for existing drugs, offering hope and potentially saving countless lives.